| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +3K | 0.8% | $27.66 | +$83K |
| Sells | 10 | -359K | 99.2% | $31.72 | -$11.4M |
| Net | -9 | -356K | -98.3% | -$11.3M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Christopher Anzalone | Chief Executive Officer, Director | $122M | -$4.72M | -3.74% | Jan 31, 2024 |
| Patrick O'Brien | COO and General Counsel | $17.4M | -$1.14M | -6.17% | Jan 3, 2024 |
| Kenneth Myszkowski | Chief Financial Officer | $14.1M | -$1.98M | -12.3% | Mar 6, 2024 |
| Javier San | Chief Medical Officer | $7.42M | -$860K | -10.4% | Jan 4, 2024 |
| James Hamilton | Chief Discovery/Trans Medicine | $5.74M | -$1.79M | -23.8% | Apr 1, 2024 |
| Douglas B. Given | Director | $4.85M | -$111K | -2.23% | Jan 11, 2024 |
| Michael Perry | Director | $4.29M | Dec 15, 2023 | ||
| James Hassard | Chief Commercial Officer | $3.95M | Jun 22, 2021 | ||
| Tracie Oliver | Chief Commercial Officer | $3.21M | -$240K | -6.95% | Jul 2, 2024 |
| Mauro Ferrari | Director | $2.27M | -$120K | -5.01% | Jan 11, 2024 |
| William D. Waddill | Director | $1.79M | -$150K | -7.72% | Jan 11, 2024 |
| Marianne De Backer | Director | $1.17M | Jan 10, 2023 | ||
| Hongbo Lu | Director | $926K | +$83K | +9.84% | Mar 18, 2024 |
| Adeoye Y. Olukotun | Director | $854K | Dec 15, 2023 | ||
| Victoria Vakiener | Director | $704K | -$263K | -27.2% | May 2, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|